Urovant is a California-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of urologic conditions... Read more
Urovant is a California-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of urologic conditions... Read more
News
Apr 04, 2023
StreetInsider
Press Release: Urovant Sciences : Sumitomo Pharma Subsidiary Companies in the U.S., Including Sunovion, to Combine and Form Sumitomo Pharma America
Jan 26, 2023
Drug Store News
Urovant Sciences: Urovant Sciences, Holly Robinson Peete raise awareness for overactive bladders
Nov 14, 2022
BioSpace
Urovant Sciences: Urovant Sciences Announces Partnership with Thinx Inc. to Help Americans with Overactive Bladder This Travel Season
Oct 27, 2022
Acrofan
Urovant Sciences: Urovant Sciences Announces Publication of Pharmacokinetic Data on GEMTESA (Vibegron 75mg) Administered as an Intact or Crushed Tablet
Sep 08, 2022
FinanzNachrichten
Urovant Sciences: Urovant Sciences GmbH: Urovant Sciences Receives "Best in Category" Award for Abstract Highlighting Investigational Novel Gene Therapy, URO-902, Presented at 2022 International Continence Society Conference
Sep 07, 2022
Portada
Urovant Sciences: Urovant Sciences Named 17th on the List of Fortune Best Workplaces in BioPharma (2022)
Jul 25, 2022
PharmaLive
Urovant Sciences: Urovant is Getting Really Good at Urology: Specialization Leading to Innovation
Jul 13, 2022
Business Wire
Press Release: Urovant Sciences : The Impact of Urinary Incontinence Related to Overactive Bladder on Long-Term Care Residents and Facilities in the U.S. Highlighted in New Survey
Jul 08, 2022
Medthority
Urovant Sciences: Urovant Sciences + Pierre Fabre Mdicament enter into exclusive license agreement for vibegron for the treatment of overactive bladder in the European Economic Area, UK, and Switzerland
Jul 07, 2022
Acrofan
Urovant Sciences: Urovant Sciences Named One of 2022 "Best Places to Work" in Orange County
Urovant Sciences Competitors
1
2
3
4
5
6
7
8
9
10